USE OF FLUOXETINE, VENLAFAXINE, MILNACIPRAN AND DULOXETINE WITH A SYNERGIST IN PHARMACEUTICAL COMPOSITIONS

摘要

The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.